Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma
NCT02784015 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 41
Last updated 2018-09-18
Summary
To evaluate the treatment outcome of unresectable soft tissue sarcoma using response based treatment
Conditions
- Unresectable Localized Soft Tissue Sarcoma
Interventions
- DRUG
- DRUG
-
Etoposide
- DRUG
-
Doxorubicin
- DRUG
- DRUG
-
Ifosfamide
- DRUG
- RADIATION
-
Radiotherapy
- DRUG
-
Thiotepa
- DRUG
-
Melphalan
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-05-31
- Primary Completion
- 2020-05-31
- Completion
- 2023-05-31
Countries
- South Korea
Study Locations
More Related Trials
-
Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors
NCT02756845 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children
NCT04659733 ·Status: UNKNOWN ·Phase: PHASE1
-
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
NCT05634369 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma
NCT00003801 ·Status: COMPLETED ·Phase: NA
-
Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas
NCT06476704 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
NCT06156410 ·Status: RECRUITING ·Phase: PHASE1
-
A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy
NCT04478292 ·Status: RECRUITING ·Phase: PHASE3
-
Paclitaxel/Ifosfamide/Cisplatin Chemotherapy for High Risk Pediatric Germ Cell Tumor
NCT05455918 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
NCT05135975 ·Status: RECRUITING ·Phase: PHASE2
-
Anlotinib Hydrochloride Capsules in Maintenance Treatment for Intermediate-High Risk Rhabdomyosarcoma in Children
NCT07137884 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone
NCT01288573 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Multi-Center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669) Administered QDX5 Every Other Week in Pediatric Patients With Advanced Solid Tumors (8669-028)(COMPLETED)
NCT00704054 ·Status: COMPLETED ·Phase: PHASE1
-
EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children
NCT00339118 ·Status: UNKNOWN ·Phase: PHASE4
-
Phase I Study of Safety and Feasibility of Transarterial Embolization of Incurable Hypervascular Pediatric Soft Tissue Sarcomas
NCT07136571 ·Status: WITHDRAWN ·Phase: NA
-
Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue Sarcomas
NCT01216839 ·Status: UNKNOWN ·Phase: PHASE2
-
Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]
NCT03686566 ·Status: COMPLETED
-
Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas
NCT02409576 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
An Analysis of the Efficacy of High Dose Isofosfamide Through Elastomer
NCT04651569 ·Status: COMPLETED
-
Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors
NCT05608148 ·Status: RECRUITING ·Phase: PHASE1
-
Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma
NCT00923351 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
NCT06941272 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas
NCT00001566 ·Status: COMPLETED ·Phase: PHASE2
-
A Prediction Model of Hematological Recovery After High-dose Chemotherapy in Pediatric Solid Tumor
NCT05024331 ·Status: COMPLETED
-
Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS)
NCT03441360 ·Status: COMPLETED ·Phase: PHASE2
-
Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors
NCT03611595 ·Status: RECRUITING ·Phase: PHASE1